- Antitumor activity of orally bioavailable farnesyltransferase inhibitor, ABT-100, is mediated by antiproliferative, proapoptotic, and antiangiogenic effects in xenograft models. Ferguson, D., Rodriguez, L.E., Palma, J.P., Refici, M., Jarvis, K., O'Connor, J., Sullivan, G.M., Frost, D., Marsh, K., Bauch, J., Zhang, H., Lin, N.H., Rosenberg, S., Sham, H.L., Joseph, I.B. Clin. Cancer Res. (2005)